Literature DB >> 6973357

Separation and characterization of hexokinase I subtypes from human erythrocytes.

G Rijksen, G Jansen, R J Kraaijenhagen, M J Van der Vlist, A M Vlug, G E Staal.   

Abstract

Hexokinase (ATP: D-hexose 6-phosphotransferase, EC 2.7.1.1) type 1 from human erythrocytes exists in four electrophoretical distinct forms, termed Ia, Ib, Ic and Id in order of their increasing anodal electrophoretic mobility at pH 8.8. We were able to separate type Ia, Ib and Icd on phosphocellulose by using a discontinuous gradient elution. The three chromatographically distinct forms do not differ in their affinity constants for the substrates glucose and MgATP2-. In addition the inhibition by glucose 1,6-diphosphate does not differ significantly for all forms. However, the regulation of these inhibitions by inorganic phosphate is much less for type Ia compared to the other subtypes (P = 0.001). Aging of the red cells is accompanied by a relative increase of the proportion of type Ic and Ia, which is the less regulated form of the enzyme. This shift in electrophoretic and regulatory properties is argued to be due to a post-translational modification of the primary enzyme.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973357     DOI: 10.1016/0005-2744(81)90055-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: equations and parameter refinement.

Authors:  P J Mulquiney; P W Kuchel
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

2.  Molecular forms of red blood cell hexokinase.

Authors:  G Fornaini; M Dachà; M Magnani; V Stocchi
Journal:  Mol Cell Biochem       Date:  1982-12-10       Impact factor: 3.396

3.  Hexokinase type I multiplicity in human erythrocytes.

Authors:  M Magnani; G Serafini; V Stocchi
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.